loe 908 has been researched along with Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bareyre, FM; Brown, AL; Cheney, JA; Ensinger, HA; Leusch, A; Raghupathi, R; Russ, AB; Saatman, KE; Weisser, JD | 1 |
| Busch, U; Eichhorn, B; Ensinger, HA; Leusch, A | 1 |
2 other study(ies) available for loe 908 and Brain Injuries
| Article | Year |
|---|---|
The novel compound LOE 908 attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats.
Topics: Acetamides; Animals; Brain Injuries; Catheterization; Cerebral Cortex; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Isoquinolines; Male; Memory Disorders; Motor Skills Disorders; Neurologic Examination; Rats; Rats, Sprague-Dawley; Time Factors; Wounds, Nonpenetrating | 2000 |
Pharmacokinetics of pinokalant, a new nonselective cation channel blocker in the rat.
Topics: Acetamides; Animals; Bile; Blood Proteins; Blood-Brain Barrier; Brain Injuries; Chromatography, High Pressure Liquid; Feces; Female; Injections, Intravenous; Ion Channels; Isoquinolines; Male; Middle Cerebral Artery; Protein Binding; Rats; Spectrometry, Fluorescence | 2001 |